Ledger. Australian venture funding, tracked

Venture capital fund · 5 deals

T. Rowe Price

Coverage

Stories naming T. Rowe Price. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Series D+ ~$452m

Brisbane biotech AdvanCell just raised a record $450 million

Brisbane radiopharmaceutical developer AdvanCell has closed an oversubscribed Series D round, led by Ally Bridge Group and Alpha Wave with several institutional investors returning, to fund late-stage prostate cancer trials and US manufacturing.

2 deals

Airwallex worth $16 billion after $460 million Series H

Airwallex has closed a Series H valuing it at $16 billion, with Addition in the lead and eight other backers named; the piece also recalls its December Series G.

Also Startup Daily·Cut Through Venture

2 deals

Baseten: the whole game

Blackbird's post explaining its participation in Baseten's $1.5 billion Series F, its biggest investment yet, and why inference infrastructure will anchor the open-source AI era; notes rapid growth and senior engineering hires.

Also Dealroom

13 deals

Six ANZ startups that raised $568.1 million this week

Funding roundup led by Airwallex's US$330 million Series G at a $12 billion valuation, with raises from Kasada, Hnry, All G, Bless Payments and Emanda, plus earlier rounds recalled.

Also Startup Daily

2 deals

Airwallex raises a blockbuster $498 million Series G as its valuation soars to $12 billion

Fintech Airwallex raised a $498 million Series G led by Addition, lifting its valuation to $12 billion; Square Peg and Airtree joined, and Blackbird's $60 million May Series F backing is recalled.

Also SmartCompany·Cut Through Venture·SmartCompany·Dealroom

undisclosed

Canva hits $42B valuation in secondary sale, joining Figma in pre-IPO spotlight

Canva launched an employee share sale valuing the design software firm at $42 billion, led by Fidelity with JPMorgan's asset arm joining, ahead of a planned IPO; US rival Figma listed last month.

Also Crunchbase News·stratechery.com·Crunchbase News

Something wrong? Tell us